Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $6,975 | 3 | 46.8% |
| Unspecified | $6,300 | 1 | 42.2% |
| Food and Beverage | $715.22 | 8 | 4.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $675.00 | 1 | 4.5% |
| Travel and Lodging | $253.24 | 1 | 1.7% |
| Education | $0.83 | 1 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ChiRhoClin, Inc. | $6,300 | 1 | $0 (2019) |
| ABBVIE INC. | $4,626 | 5 | $0 (2022) |
| Nestle HealthCare Nutrition Inc. | $2,025 | 1 | $0 (2022) |
| Zyla Life Sciences, Inc. | $750.00 | 1 | $0 (2023) |
| PFIZER INC. | $675.00 | 1 | $0 (2023) |
| Ipsen Biopharmaceuticals, Inc | $288.49 | 2 | $0 (2024) |
| Boston Scientific Corporation | $217.38 | 2 | $0 (2018) |
| Allergan Inc. | $36.18 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $148.92 | 1 | Ipsen Biopharmaceuticals, Inc ($148.92) |
| 2023 | $1,425 | 2 | Zyla Life Sciences, Inc. ($750.00) |
| 2022 | $2,189 | 4 | Nestle HealthCare Nutrition Inc. ($2,025) |
| 2019 | $6,300 | 1 | ChiRhoClin, Inc. ($6,300) |
| 2018 | $150.69 | 2 | Boston Scientific Corporation ($114.51) |
| 2017 | $4,706 | 5 | AbbVie, Inc. ($4,603) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/09/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $148.92 | General |
| Category: Oncology | ||||||
| 06/15/2023 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $675.00 | General |
| 03/10/2023 | Zyla Life Sciences, Inc. | SPRIX (Drug) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: Pain Medicine | ||||||
| 12/22/2022 | Travere Therapeutics, Inc. | Cholbam (Drug) | Education | In-kind items and services | $0.83 | General |
| Category: Hepatology | ||||||
| 11/11/2022 | Ipsen Biopharmaceuticals, Inc | ONIVYDE (Drug) | Food and Beverage | In-kind items and services | $139.57 | General |
| Category: Oncology | ||||||
| 08/24/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Consulting Fee | Cash or cash equivalent | $2,025.00 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 05/22/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/26/2019 | ChiRhoClin, Inc. | ChiRhoStim (Drug) | — | In-kind items and services | $6,300.00 | Research |
| Study: MINIMAP • Category: Diagnostic | ||||||
| 06/02/2018 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $36.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/16/2018 | Boston Scientific Corporation | GENERAL THERAPIES (Device) | Food and Beverage | In-kind items and services | $114.51 | General |
| Category: THERAPIES | ||||||
| 12/13/2017 | AbbVie, Inc. | Creon (Drug) | Consulting Fee | Cash or cash equivalent | $4,200.00 | General |
| Category: Endocrinology | ||||||
| 11/11/2017 | AbbVie, Inc. | Creon (Drug) | Travel and Lodging | In-kind items and services | $253.24 | General |
| Category: Endocrinology | ||||||
| 11/11/2017 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $29.16 | General |
| Category: Endocrinology | ||||||
| 11/07/2017 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $120.23 | General |
| Category: Endocrinology | ||||||
| 11/04/2017 | BOSTON SCIENTIFIC CORPORATION | GENERAL - BILIARY DEVICES (Device) | Food and Beverage | In-kind items and services | $102.87 | General |
| Category: BILIARY DEVICES | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| MINIMAP | ChiRhoClin, Inc. | $6,300 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 11 | 21 | $6,734 | $1,401 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 11 | 21 | $6,734 | $1,401 | 20.8% |
About Dr. Stephen Pandol, MD
Dr. Stephen Pandol, MD is a Internal Medicine healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891892774.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Pandol, MD has received a total of $14,919 in payments from pharmaceutical and medical device companies, with $148.92 received in 2024. These payments were reported across 15 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($6,975).
As a Medicare-enrolled provider, Pandol has provided services to 11 Medicare beneficiaries, totaling 21 services with total Medicare billing of $1,401. Data is available for 1 year (2023–2023), covering 1 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Los Angeles, CA
- Active Since 09/20/2006
- Last Updated 08/16/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1891892774
Products in Payments
- ChiRhoStim (Drug) $6,300
- Creon (Drug) $4,603
- ZENPEP (Drug) $2,025
- SPRIX (Drug) $750.00
- Onivyde (Drug) $148.92
- ONIVYDE (Drug) $139.57
- GENERAL THERAPIES (Device) $114.51
- GENERAL - BILIARY DEVICES (Device) $102.87
- VIBERZI (Drug) $36.18
- CREON (Drug) $23.78
- Cholbam (Drug) $0.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Los Angeles
Dr. Thomas Magee, Md, MD
Internal Medicine — Payments: $1.2M
Dr. Julio Gutierrez, Md, MD
Internal Medicine — Payments: $920,439
Dr. Mohammad Kamgar, M.d, M.D
Internal Medicine — Payments: $471,176
Dr. Caroline Piatek, M.d,, M.D,
Internal Medicine — Payments: $468,526
Gottfried Konecny, Md, MD
Internal Medicine — Payments: $399,651
Dr. Elizabeth Volkmann, Md, MD
Internal Medicine — Payments: $397,666